Related Experiment Video

Updated: Aug 26, 2025

A Method for Measuring RNA N6-methyladenosine Modifications in Cells and Tissues
08:56

A Method for Measuring RNA N6-methyladenosine Modifications in Cells and Tissues

Published on: December 5, 2016

11.0K

Targeting N6-methyladenosine RNA modification combined with immune checkpoint Inhibitors: A new approach for cancer

Weiwei Liu1,2, Chaoqun Liu1,2, Hui Wang3

  • 1Department of Pathology, Nanfang Hospital, Southern Medical University, Guangzhou, China.

Computational and Structural Biotechnology Journal
|October 3, 2022
PubMed

Insights

N6-methyladenosine (m6A) epigenetic modification shows promise in enhancing the effectiveness of immune checkpoint inhibitors (ICIs) for cancer immunotherapy. Targeting m6A may offer a new strategy to overcome resistance and improve patient outcomes.

Area of Science:

  • Oncology
  • Immunology
  • Epigenetics

Background:

  • Immune checkpoint inhibitors (ICIs) have transformed cancer treatment, improving survival for some patients.
  • However, low response rates limit the clinical application of ICIs across various cancers.
  • Resistance to ICI therapy remains a significant challenge in oncology.

Purpose of the Study:

  • To review the role of N6-methyladenosine (m6A) modification in tumor immunity and ICI treatment.
  • To explore how m6A epigenetic modifications influence response to ICI therapy.
  • To propose m6A-targeting as a potential strategy to enhance ICI efficacy.

Main Methods:

  • Literature review of tumor immunity mechanisms.
  • Analysis of clinical applications and resistance patterns of ICIs.
  • Examination of m6A epigenetic modification and its regulatory functions.

Main Results:

  • m6A modification is the most prevalent RNA methylation.
  • Emerging evidence suggests m6A can improve ICI treatment efficacy.
  • Understanding m6A regulation is key to overcoming ICI resistance.

Conclusions:

  • m6A epigenetic modification presents a promising avenue for improving cancer immunotherapy.
  • Combined targeting of m6A and ICIs could offer a novel therapeutic strategy.
  • Further research into m6A-mediated regulation may unlock new cancer treatment possibilities.
Keywords:
Cancer immunotherapyICBM6A modificationm6A regulators

More Related Videos

Characterizing RNA Modifications in Single Neurons Using Mass Spectrometry08:45

Characterizing RNA Modifications in Single Neurons Using Mass Spectrometry

Published on: April 21, 2022

2.5K
Methylated RNA Immunoprecipitation Assay to Study m5C Modification in Arabidopsis08:50

Methylated RNA Immunoprecipitation Assay to Study m5C Modification in Arabidopsis

Published on: May 14, 2020

6.8K

Related Concept Videos

Experimental RNAi02:15

Experimental RNAi

RNA interference (RNAi) is a cellular mechanism that inhibits gene expression by suppressing its transcription or activating the RNA degradation process. The mechanism was discovered by Andrew Fire and Craig Mello in 1998 in plants. Today, it is observed in almost all eukaryotes, including protozoa, flies, nematodes, insects, parasites, and mammals. This precise cellular mechanism of gene silencing has been developed into a technique that provides an efficient way to identify and determine the...
6.2K
RNA Editing02:23

RNA Editing

RNA editing is a post-transcriptional modification where a precursor mRNA (pre-mRNA) nucleotide sequence is changed by base insertion, deletion, or modification. The extent of RNA editing varies from a few hundred bases, in mitochondrial DNA of trypanosomes, to a just single base, in nuclear genes of mammals. Even a single base change in the pre-mRNA can convert a codon for one amino acid into the codon for another amino acid or a stop codon. This type of re-coding can significantly affect the...
9.1K
MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns (non-coding regions of a gene) or intergenic regions (stretches of DNA present between genes). Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself, forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA...
3.1K
RNA Interference01:23

RNA Interference

RNA interference (RNAi) is a process in which a small non-coding RNA molecule blocks the post-transcriptional expression of a gene by binding to its messenger RNA (mRNA) and preventing the protein from being translated.
This process occurs naturally in cells, often through the activity of genomically-encoded microRNAs. Researchers can take advantage of this mechanism by introducing synthetic RNAs to deactivate specific genes for research or therapeutic purposes. For example, RNAi could be used...
26.3K
Tumor Immunotherapy01:27

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
642
siRNA - Small Interfering RNAs02:30

siRNA - Small Interfering RNAs

Small interfering RNAs, or siRNAs, are short regulatory RNA molecules that can silence genes post-transcriptionally, as well as the transcriptional level in some cases. siRNAs are important for protecting cells against viral infections and silencing transposable genetic elements.
In the cytoplasm, siRNA is processed from a double-stranded RNA, which comes from either endogenous DNA transcription or exogenous sources like a virus. This double-stranded RNA is then cleaved by the...
16.9K